1
|
Abstract
PURPOSE The current review is to describe the definition and prevalence of resistant arterial hypertension (RAH), the difference between refractory hypertension, patient characteristics and major risk factors for RAH, how RAH is diagnosed, prognosis and outcomes for patients. MATERIALS AND METHODS According to the WHO, approximately 1.28 billion adults aged 30-79 worldwide have arterial hypertension, and over 80% of them do not have blood pressure (BP) under control. RAH is defined as above-goal elevated BP despite the concurrent use of 3 or more classes of antihypertensive drugs, commonly including a long-acting calcium channel blocker, an inhibitor of the renin-angiotensin system (angiotensin-converting enzyme inhibitor or angiotensin receptor blocker), and a thiazide diuretic administered at maximum or maximally tolerated doses and at appropriate dosing frequency. RAH occurs in nearly 1 of 6 hypertensive patients. It often remains unrecognised mainly because patients are not prescribed ≥3 drugs at maximal doses despite uncontrolled BP. CONCLUSION RAH distinctly increases the risk of developing coronary artery disease, heart failure, stroke and chronic kidney disease and confers higher rates of major adverse cardiovascular events as well as increased all-cause mortality. Timely diagnosis and treatment of RAH may mitigate the associated risks and improve short and long-term prognosis.
Collapse
|
2
|
Chen Y, Liu N, Guo Y, Zheng C, Fu D, Cai Y, Nie K, Xia L. Effect of Liuzijue exercise in different periods on circadian rhythm of blood pressure in patients with essential hypertension: A randomized trial. Medicine (Baltimore) 2023; 102:e36481. [PMID: 38050268 PMCID: PMC10695507 DOI: 10.1097/md.0000000000036481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/22/2023] [Accepted: 11/14/2023] [Indexed: 12/06/2023] Open
Abstract
BACKGROUND Exercising at different times of the day is a widely employed strategy for treating essential hypertension, aimed at enhancing the circadian rhythm of blood pressure. This study aimed to investigate the effects of Liuzijue exercise in the morning and afternoon on the circadian rhythm of blood pressure in patients with essential hypertension. METHODS This clinical randomized trial recruited 36 patients. They were randomly divided into 3 groups: morning exercise, afternoon exercise, and waiting treatment group. Randomization was performed at a ratio of 1:1:1, ensuring an equal distribution of participants among the 3 groups. Based on maintaining routine work and rest and continuing the original drug treatment, the exercise performed Liuzijue exercise for 12 weeks. The exercise time was 9:00 to 10:00 in the morning exercise group and 14:00 to 15:00 in the afternoon exercise group. The waiting treatment group did not perform any form of fitness exercise. The subjects in the 3 groups were monitored by 24-hour ambulatory blood pressure on the day before and after the first day. RESULTS After the 12-week Liuzijue exercise intervention, mean systolic blood pressure during the night significantly decreased in the morning exercise group (P < .01). In contrast, the waiting group experienced substantial increases in 24-hour mean systolic blood pressure (24hSBP), 24-hour mean diastolic blood pressure (24hDBP), mean systolic blood pressure during the daytime (dSBP), and mean diastolic blood pressure during the daytime (dDBP) (P < .01). Further analysis showed that the morning exercise group had significantly lower 24hSBP, 24hDBP, dSBP, dDBP, and mean systolic blood pressure during the night than the waiting group (P < .05). Additionally, the morning exercise group had lower 24hSBP and dSBP levels than the afternoon exercise group (P < .05). In contrast, the afternoon exercise group had lower 24hDBP and dDBP than the waiting treatment group (P < .05). CONCLUSIONS The 12-week Liuzijue exercise in the morning regimen demonstrated superior efficacy in reducing 24-hour ambulatory blood pressure levels among patients with essential hypertension. Moreover, it facilitates the transition of non-dipper blood pressure patterns to dippers, thereby rectifying aberrant circadian rhythms.
Collapse
Affiliation(s)
- Yixiao Chen
- School of Health Preservation and Rehabilitation, Chengdu University of TCM, Chengdu, China
- People’s Republic of China – Key Laboratory of Traditional Chinese Medicine Regimen and Health Industry Development, State Administration of TCM, Sichuan, China
- Key Laboratory of Traditional Chinese Medicine Health Preservation and Wellness in Sichuan Province, Sichuan, China
| | - Nannan Liu
- School of Health Preservation and Rehabilitation, Chengdu University of TCM, Chengdu, China
- People’s Republic of China – Key Laboratory of Traditional Chinese Medicine Regimen and Health Industry Development, State Administration of TCM, Sichuan, China
- Key Laboratory of Traditional Chinese Medicine Health Preservation and Wellness in Sichuan Province, Sichuan, China
| | - Yuyan Guo
- Chongqing Bishan District Medical and Health Affairs Center, Chongqin, China
| | | | - Dijun Fu
- The Southwest Hospital of AMU, Chongqin, China
| | - Yugang Cai
- The Daying Hospital of Traditional Chinese Medicine in Suining City, Suning, China
| | - Kaidi Nie
- School of Health Preservation and Rehabilitation, Chengdu University of TCM, Chengdu, China
- People’s Republic of China – Key Laboratory of Traditional Chinese Medicine Regimen and Health Industry Development, State Administration of TCM, Sichuan, China
- Key Laboratory of Traditional Chinese Medicine Health Preservation and Wellness in Sichuan Province, Sichuan, China
| | - Lina Xia
- School of Health Preservation and Rehabilitation, Chengdu University of TCM, Chengdu, China
- People’s Republic of China – Key Laboratory of Traditional Chinese Medicine Regimen and Health Industry Development, State Administration of TCM, Sichuan, China
- Key Laboratory of Traditional Chinese Medicine Health Preservation and Wellness in Sichuan Province, Sichuan, China
| |
Collapse
|
3
|
The Role of Heart Rate Variability (HRV) in Different Hypertensive Syndromes. Diagnostics (Basel) 2023; 13:diagnostics13040785. [PMID: 36832273 PMCID: PMC9955360 DOI: 10.3390/diagnostics13040785] [Citation(s) in RCA: 12] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2023] [Revised: 02/05/2023] [Accepted: 02/16/2023] [Indexed: 02/22/2023] Open
Abstract
Cardiac innervation by the parasympathetic nervous system (PNS) and the sympathetic nervous system (SNS) modulates the heart rate (HR) (chronotropic activity) and the contraction of the cardiac muscle (inotropic activity). The peripheral vasculature is controlled only by the SNS, which is responsible for peripheral vascular resistance. This also mediates the baroreceptor reflex (BR), which in turn mediates blood pressure (BP). Hypertension (HTN) and the autonomic nervous system (ANS) are closely related, such that derangements can lead to vasomotor impairments and several comorbidities, including obesity, hypertension, resistant hypertension, and chronic kidney disease. Autonomic dysfunction is also associated with functional and structural changes in target organs (heart, brain, kidneys, and blood vessels), increasing cardiovascular risk. Heart rate variability (HRV) is a method of assessing cardiac autonomic modulation. This tool has been used for clinical evaluation and to address the effect of therapeutic interventions. The present review aims (a) to approach the heart rate (HR) as a CV risk factor in hypertensive patients; (b) to analyze the heart rate variability (HRV) as a "tool" to estimate the individual risk stratum for Pre-HTN (P-HTN), Controlled-HTN (C-HTN), Resistant and Refractory HTN (R-HTN and Rf-HTN, respectively), and hypertensive patients with chronic renal disease (HTN+CKD).
Collapse
|
4
|
Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension. Clin Auton Res 2023; 33:93-100. [PMID: 36696071 PMCID: PMC10182930 DOI: 10.1007/s10286-023-00927-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2022] [Accepted: 01/18/2023] [Indexed: 01/26/2023]
Abstract
PURPOSE Renal denervation (RDN) exerts sympathoinhibitory effects. No information is available, however, on whether these effects have a regional or a more generalized behavior. METHODS In 14 patients with resistant hypertension (RHT, age 58.3 ± 2.2 years, mean ± SEM), we recorded muscle and skin sympathetic nerve traffic (MSNA and SSNA, respectively) using the microneurographic technique, before, 1 month, and 3 months after RDN. Measurements included clinic blood pressure (BP), heart rate (HR), 24-h BP and HR, as well as routine laboratory and echocardiographic variables. Ten age-matched RHT patients who did not undergo RDN served as controls. RESULTS MSNA, but not SSNA, was markedly higher in RHT. RDN caused a significant reduction in MSNA 1 month after RDN, with this reduction increasing after 3 months (from 68.1 ± 2.5 to 64.8 ± 2.4 and 63.1 ± 2.6 bursts/100 heartbeats, P < 0.05). This effect was not accompanied by any significant change in SSNA (from 13.1 ± 0.5 to 13.4 ± 0.6 and 13.3 ± 0.4 bursts/min, P = NS). No quantitative or, in some cases, qualitative relationship was found between BP and the MSNA reduction induced by RDN. No significant changes in various sympathetic markers were detected in the control group who did not undergo RDN and were followed for 3-months observation. CONCLUSIONS These data provide the first evidence that RDN exerts heterogeneous effects on sympathetic cardiovascular drive, inducing a marked reduction in MSNA but not in SSNA, which appears to be within the normal range in this condition.These effects may depend on the different reflex modulation regulating neuroadrenergic drive in these cardiovascular districts.
Collapse
|
5
|
Vondrasek JD, Alkahtani SA, Al-Hudaib AA, Habib SS, Al-Masri AA, Grosicki GJ, Flatt AA. Heart Rate Variability and Chronotype in Young Adult Men. Healthcare (Basel) 2022; 10:healthcare10122465. [PMID: 36553989 PMCID: PMC9777576 DOI: 10.3390/healthcare10122465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2022] [Revised: 11/30/2022] [Accepted: 12/02/2022] [Indexed: 12/13/2022] Open
Abstract
Whether morning heart rate variability (HRV) predicts the magnitude of its circadian variation in the absence of disease or is influenced by chronotype is unclear. We aimed to quantify associations between (1) morning HRV and its diurnal change, and (2) morning HRV and a Morningness−Eveningness Questionnaire (MEQ)-derived chronotype. Resting electrocardiograms were obtained in the morning and evening on separate days in a counterbalanced order to determine the mean RR interval, root mean square of successive differences (RMSSD), and standard deviation of normal-to-normal RR intervals (SDNN) in 23 healthy men (24.6 ± 3.4 yrs; body mass index: 25.3 ± 2.8 kg/m2). The MEQ was completed during the first laboratory visit. Morning RMSSD and SDNN were significantly higher (Ps < 0.05) than evening values. Morning RMSSD and SDNN were associated with their absolute (Ps < 0.0001), and relative diurnal changes (Ps < 0.01). No associations were observed between HRV parameters and the MEQ chronotypes (Ps > 0.09). Morning HRV was a stronger determinant of its evening change than chronotype. Greater diurnal variation in HRV was dependent on higher morning values. Strategies to improve basal HRV may therefore support healthier cardio-autonomic circadian profiles in healthy young men.
Collapse
Affiliation(s)
- Joseph D. Vondrasek
- Department of Health Sciences and Kinesiology, Biodynamics and Human Performance Center, 11935 Abercorn St. Savannah, Georgia Southern University, Savannah, GA 31419, USA
| | - Shaea A. Alkahtani
- Department of Exercise Physiology, College of Sport Sciences and Physical Activity, King Saud University, Riyadh 11451, Saudi Arabia
- Correspondence:
| | - Abdulrahman A. Al-Hudaib
- Department of Exercise Physiology, College of Sport Sciences and Physical Activity, King Saud University, Riyadh 11451, Saudi Arabia
| | - Syed Shahid Habib
- Department of Physiology, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia
| | - Abeer A. Al-Masri
- Department of Physiology, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia
| | - Gregory J. Grosicki
- Department of Health Sciences and Kinesiology, Biodynamics and Human Performance Center, 11935 Abercorn St. Savannah, Georgia Southern University, Savannah, GA 31419, USA
| | - Andrew A. Flatt
- Department of Health Sciences and Kinesiology, Biodynamics and Human Performance Center, 11935 Abercorn St. Savannah, Georgia Southern University, Savannah, GA 31419, USA
| |
Collapse
|
6
|
Hong KE, Kim SA, Shin DY, Park CK, Park HYL. Ocular and Hemodynamic Factors Contributing to the Central Visual Function in Glaucoma Patients With Myopia. Invest Ophthalmol Vis Sci 2022; 63:26. [PMID: 35604665 PMCID: PMC9150826 DOI: 10.1167/iovs.63.5.26] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2021] [Accepted: 04/28/2022] [Indexed: 11/24/2022] Open
Abstract
Purpose The purpose of this study was to investigate the ocular and hemodynamic factors contributing to the central visual function in glaucoma patients with myopia. Methods This study was a prospective observational study, which included 236 eyes of 140 patients with normal-tension glaucoma (NTG), which includes 114 eyes with mild myopia (axial length ≥24 and <26 mm) and 122 eyes with moderate-to-severe myopia (axial length ≥26 mm). Ocular characteristics were axial length and posterior pole profiles, including peripapillary atrophy (PPA) to disc area ratio, disc tilt ratio, disc torsion, and disc-foveal angle. Hemodynamic factors included standard deviation of the mean of qualified normal-to-normal intervals (SDNN) of a heart rate variability (HRV) test and vessel density (VD) parameters from optical coherence tomography angiography (OCTA). The root mean square error was estimated as a measure of the VD fluctuation. Association between ocular characteristics and VD parameters of the OCTA with the central sensitivity of the 10-degree visual field or the presence of central scotoma were analyzed. Results Deep layer VD of the peripapillary and macular areas showed significant differences between mild and moderate-to-severe myopia (P = 0.034 and P = 0.045, respectively). Structural parameters, especially PPA to disc area ratio, had significant correlation with peripapillary VD parameters in myopic eyes. Lower SDNN value (ß = 0.924, P = 0.011), lower deep VD of the macular area (ß = 0.845, P = 0.001), and greater fluctuation of deep VD in the peripapillary area (ß = 1.517, P = 0.005) were associated with the presence of central scotoma in patients with glaucoma with myopia in multivariate logistic regression analysis. Conclusions The structural changes by myopia, especially in the peripapillary region, affected VD parameters in myopic eyes. Lower deep VD and greater VD fluctuation in the peripapillary region showed association with central scotoma in patients with glaucoma with myopia, suggesting both structural and vascular changes by myopia may be related to central visual function in glaucoma patients with myopia.
Collapse
Affiliation(s)
- Kyung Euy Hong
- Department of Ophthalmology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Seong Ah Kim
- Department of Ophthalmology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Da-Young Shin
- Department of Ophthalmology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Chan Kee Park
- Department of Ophthalmology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Hae-Young Lopilly Park
- Department of Ophthalmology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| |
Collapse
|
7
|
Huyut M, Levent F, Tutuncu A, Ozmen G, Ormanci D, Vatansever F. The effect of COVID-19 infection on heart rate variability: A cross-sectional study. INTERNATIONAL JOURNAL OF THE CARDIOVASCULAR ACADEMY 2022. [DOI: 10.4103/ijca.ijca_9_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023] Open
|
8
|
Di Raimondo D, Musiari G, Casuccio A, Colomba D, Rizzo G, Pirera E, Pinto A, Tuttolomondo A. Cardiac Remodeling According to the Nocturnal Fall of Blood Pressure in Hypertensive Subjects: The Whole Assessment of Cardiac Abnormalities in Non-Dipper Subjects with Arterial Hypertension (Wacanda) Study. J Pers Med 2021; 11:jpm11121371. [PMID: 34945843 PMCID: PMC8704210 DOI: 10.3390/jpm11121371] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2021] [Revised: 12/06/2021] [Accepted: 12/13/2021] [Indexed: 01/31/2023] Open
Abstract
Objective: Several epidemiological studies suggest that the preservation of the physiological circadian rhythm of blood pressure or its disruption affects the extent of the organ damage developed by the patient. If we classify the circadian rhythm of blood pressure into four nocturnal profiles, significant differences emerge in terms of organ damage burden and prognosis: reverse dippers have the worst prognosis while dippers and mild dippers fall into an intermediate risk range. The risk profile of extreme dippers is still debated, and the available data are very conflicting and inconclusive. Starting from this gap of knowledge, we aimed to evaluate, retrospectively, in a cohort of hypertensive subjects, the degree of cardiac involvement in relation to the different nocturnal blood pressure profiles. Methods: We retrospectively evaluated 900 patients with essential hypertension, of whom 510 met our study criteria. We graded the 510 patients in relation to the percentage of reduction in mean systolic blood pressure (SBP) at night-time compared with day-time, considering this as a continuous variable, and then compared the extreme quintiles with each other and with the middle quintile (considered as reference). Results: Patients with less (or no) reduction in nocturnal SBP (reverse dipper) showed a higher level of organ damage and comorbidities. With regard to echocardiographic indexes, patients with maximum nocturnal pressure reduction (extreme dipper) showed a lower level of remodeling and/or impairment of E/e’ ratio, Right Atrium Area, Basal Right Ventricular Diameter, Inferior Vena Cava Average Diameter, and Tricuspidal Anular Plane Systolic Excursion compared also with hypertensive patients with a physiological nocturnal pressure reduction, even after correction for the main confounders. Conclusions: These data suggest that extreme dippers may constitute the subgroup of hypertensive patients with the lowest 24-h pressure load and, therefore, less cardiac remodeling.
Collapse
|
9
|
Cilhoroz B, Giles D, Zaleski A, Taylor B, Fernhall B, Pescatello L. Validation of the Polar V800 heart rate monitor and comparison of artifact correction methods among adults with hypertension. PLoS One 2020; 15:e0240220. [PMID: 33031480 PMCID: PMC7544136 DOI: 10.1371/journal.pone.0240220] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Accepted: 09/22/2020] [Indexed: 11/18/2022] Open
Abstract
Heart rate variability (HRV) measurements via ambulatory monitors have become common. We examined the validity of recording R-R intervals using the Polar V800™ compared to 12-lead electrocardiograms (ECG) among middle-aged (44.7±10.1years); overweight to obese (29.8±4.3 kg.m-2) adults (n = 25) with hypertension (132.3±12.2/ 84.3±10.2 mmHg). After resting for 5-min in the supine position, R-R intervals were simultaneously recorded using the Polar V800™ and the 12-lead ECG. Artifacts present in uncorrected (UN) R-R intervals were corrected with the Kubios HRV Premium (ver. 3.2.) automatic (AC) and threshold-based (TBC) correction, and manual correction (MC) methods. Intra-class correlation coefficients (ICC), Bland-Altman limits of agreement (LoA), and effect sizes (ES) were calculated. We detected 71 errors with the Polar V800™ for an error rate of 0.85%. The bias (LoAs), ES, and ICC between UN and ECG R-R intervals were 0.69ms (-215.80 to +214.42ms), 0.004, and 0.79, respectively. Correction of artifacts improved the agreeability between the Polar V800™ and ECG HRV measures. The biases (LoAs) between the AC, TBC, and MC and ECG R-R intervals were 3.79ms (-130.32 to +137.90ms), 1.16ms (-92.67 to +94.98ms), and 0.37ms (-41.20 to +41.94ms), respectively. The ESs of AC, TBC, and MC were 0.024, 0.008, and 0.002, and ICCs were 0.91, 0.95, and 1.00, respectively. R-R intervals measured using the Polar V800™ compared to 12-lead ECG were comparable in adults with hypertension, especially after the artifacts corrected by MC. However, TBC correction also yielded acceptable results.
Collapse
Affiliation(s)
- Burak Cilhoroz
- Department of Kinesiology, University of Connecticut, Storrs, Connecticut, United States of America
- Department of Exercise Science, Syracuse University, Syracuse, New York, United States of America
- * E-mail:
| | - David Giles
- Health and Social Care Research Centre, University of Derby, Derby, United Kingdom
| | - Amanda Zaleski
- Department of Kinesiology, University of Connecticut, Storrs, Connecticut, United States of America
- Department of Preventive Cardiology, Hartford Hospital, Hartford, Connecticut, United States of America
| | - Beth Taylor
- Department of Kinesiology, University of Connecticut, Storrs, Connecticut, United States of America
- Department of Preventive Cardiology, Hartford Hospital, Hartford, Connecticut, United States of America
| | - Bo Fernhall
- College of Applied Health Sciences, University of Illinois at Chicago, Chicago, Illinois, United States of America
| | - Linda Pescatello
- Department of Kinesiology, University of Connecticut, Storrs, Connecticut, United States of America
- Institute for Systems Genomics, University of Connecticut, Storrs, Connecticut, United States of America
| |
Collapse
|
10
|
Abstract
The cumulative science linking stress to negative health outcomes is vast. Stress can affect health directly, through autonomic and neuroendocrine responses, but also indirectly, through changes in health behaviors. In this review, we present a brief overview of (a) why we should be interested in stress in the context of health; (b) the stress response and allostatic load; (c) some of the key biological mechanisms through which stress impacts health, such as by influencing hypothalamic-pituitary-adrenal axis regulation and cortisol dynamics, the autonomic nervous system, and gene expression; and (d) evidence of the clinical relevance of stress, exemplified through the risk of infectious diseases. The studies reviewed in this article confirm that stress has an impact on multiple biological systems. Future work ought to consider further the importance of early-life adversity and continue to explore how different biological systems interact in the context of stress and health processes.
Collapse
Affiliation(s)
- Daryl B O'Connor
- School of Psychology, University of Leeds, Leeds LS2 9JT, United Kingdom;
| | - Julian F Thayer
- Department of Psychological Science, School of Social Ecology, University of California, Irvine, California 92697, USA;
| | - Kavita Vedhara
- Division of Primary Care, School of Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom;
| |
Collapse
|
11
|
ButtÀ C, Tuttolomondo A, Casuccio A, DI Raimondo D, Miceli G, Cuttitta F, Zappulla V, Corpora F, Pinto A. Autonomic dysfunction in a group of lower extremities arterial disease outpatients. Minerva Cardiol Angiol 2020; 69:28-35. [PMID: 32643892 DOI: 10.23736/s2724-5683.20.05094-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
BACKGROUND The understanding of the specific role of sympathetic neural control and dysregulation in lower extremities arterial disease (LEAD) is still very limited. Aim of our study was to investigate the autonomic profile in LEAD patients and to evaluate if the eventual autonomic alterations were more severe in patients with advanced disease. METHODS We enrolled all consecutive outpatients with LEAD referred to our Departments between July 2012 and September 2014. They were compared to a group of matched outpatients without LEAD. All patients underwent Holter ECG monitoring. Time-domain analysis of heart rate variability (HRV) was evaluated. RESULTS Compared to controls, patients with LEAD had a lower SDNN (P=0.007) and SDANN (P=0.003). Patients with clinically advanced LEAD had a lower SDNN (P=0.006) and SDANN (P=0.004) compared to LEAD patients with less severe disease and to those without disease. CONCLUSIONS LEAD patients had a reduced SDNN and SDANN than patients without LEAD. Autonomic dysfunction was more significant in clinically advanced stages of disease. This association did not relate to ABI value but to clinical stage of disease.
Collapse
Affiliation(s)
- Carmelo ButtÀ
- Unit of Cardiology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy -
| | - Antonino Tuttolomondo
- Unit of Internal Medicine and Stroke, Department of Health Promotion, Maternal and Child, Internal and Specialized Medicine, University of Palermo, Palermo, Italy
| | - Alessandra Casuccio
- Department of Health Promotion, Maternal and Child, Internal and Specialized Medicine, University of Palermo, Palermo, Italy
| | - Domenico DI Raimondo
- Unit of Internal Medicine and Stroke, Department of Health Promotion, Maternal and Child, Internal and Specialized Medicine, University of Palermo, Palermo, Italy
| | - Giuseppe Miceli
- Unit of Internal Medicine and Stroke, Department of Health Promotion, Maternal and Child, Internal and Specialized Medicine, University of Palermo, Palermo, Italy
| | - Francesco Cuttitta
- Unit of Internal Medicine and Stroke, Department of Health Promotion, Maternal and Child, Internal and Specialized Medicine, University of Palermo, Palermo, Italy
| | - Valentina Zappulla
- Unit of Internal Medicine and Stroke, Department of Health Promotion, Maternal and Child, Internal and Specialized Medicine, University of Palermo, Palermo, Italy
| | - Francesca Corpora
- Unit of Internal Medicine and Stroke, Department of Health Promotion, Maternal and Child, Internal and Specialized Medicine, University of Palermo, Palermo, Italy
| | - Antonio Pinto
- Unit of Internal Medicine and Stroke, Department of Health Promotion, Maternal and Child, Internal and Specialized Medicine, University of Palermo, Palermo, Italy
| |
Collapse
|
12
|
AlJaroudi W. Heart rate and 123I-MIBG in heart failure with preserved ejection fraction: More variability and slower washout-A secret recipe for better survival. J Nucl Cardiol 2020; 27:843-848. [PMID: 30414060 DOI: 10.1007/s12350-018-01514-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2018] [Accepted: 10/30/2018] [Indexed: 10/27/2022]
Affiliation(s)
- Wael AlJaroudi
- Division of Cardiovascular Medicine, Clemenceau Medical Center, Beirut, Lebanon.
| |
Collapse
|
13
|
Kuramoto M, Aizawa M, Kuramoto Y, Okabe M, Sakata Y, Aizawa Y. Blood Pressure Increases Before Pulse Rate During the Nocturnal Period in Hypertensive Patients. Int Heart J 2020; 61:579-584. [PMID: 32418973 DOI: 10.1536/ihj.19-695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Ambulatory blood pressure monitoring (ABPM) is used for the evaluation of out-of-office blood pressure (BP), however, knowledge concerning the detailed behavior of nocturnal blood pressure (BP) and pulse rate (PR) is limited.A total of 190 participants (64 ± 15 years, 46.3% males) underwent ABPM for diagnosis of hypertension or evaluation of hypertensive therapy. BP and PR were measured automatically by the oscillometric method. From the hourly average ABPM values, the nocturnal time courses (0 AM to 6 AM) of SBP and PR were determined and compared to each other.In general, SBP fell to the lowest level at around midnight and started to increase progressively towards dawn while PR stayed unchanged until 7 AM. Age and gender affected the time course of SBP, most distinctly in the female patients aged ≥ 60 years. The time course of the increase of SBP was very similar in the patients, with BP dipping and non-dipping. The cardiothoracic ratio (CTR) slightly and renal dysfunction modestly facilitated the increase of nocturnal SBP. The nocturnal increase in SBP was not accompanied by an increase of PR in any group or subgroup. The pathophysiology and clinical significance of the early and exclusive increase in nocturnal BP need to be investigated.Average ABPM values in these hypertensive patients showed that BP starts to increase toward dawn without an increase in PR and that this discrepant behavior between BP and RP was most distinct in females 60 or older. The mechanism and clinical significance of such a discordant variation in BP and PR need to be elucidated.
Collapse
Affiliation(s)
- Miho Kuramoto
- Department of Cardiology, Osaka Hospital.,Department of Cardiology, Osaka University Graduate School of Medicine
| | | | - Yuki Kuramoto
- Department of Cardiology, Osaka University Graduate School of Medicine
| | - Masaaki Okabe
- Department of Cardiology, Tachikawa General Hospital
| | - Yasushi Sakata
- Department of Cardiology, Osaka University Graduate School of Medicine
| | - Yoshifusa Aizawa
- Department of Research and Development, Tachikawa Medical Center
| |
Collapse
|
14
|
Posterior scleral deformation and autonomic dysfunction in normal tension glaucoma. Sci Rep 2020; 10:8203. [PMID: 32424225 PMCID: PMC7235030 DOI: 10.1038/s41598-020-65037-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2019] [Accepted: 04/28/2020] [Indexed: 02/07/2023] Open
Abstract
In meta-analyses, it has been reported that myopia is a risk factor for glaucoma and there is increasing evidence that autonomic dysfunction causing vascular dysregulation or perfusion dysfunction is considered an important factor in the progression of glaucoma. There have been experimental studies to find out the association between autonomic nervous system and ocular growth, but no clinical study yet has evaluated the relationship between them. Therefore, we enrolled 208 open angle glaucoma patients and measured heart-rate-variability(HRV). We used the standard deviation value of the qualified normal to normal intervals (SDNN) parameter of HRV, which is considered an autonomic influence index and characterized the total effect of the regulation of autonomic blood circulation. Patients were classified into the two groups according to SDNN: those with low possibility of autonomic dysfunction (LoAD group) and those with high possibility of autonomic dysfunction (HiAD group). We evaluated myopic features employing a 'posterior scleral profile' identified by the disc tilt ratio, disc torsion, fovea-BMO center (FoBMO) angle and peripapapillary area(PPA) to disc ratio. HiAD group showed higher values than LoAD group in posterior scleral deformation profile such like axial length, disc tilt, torsion degree. We suggest the possibility of association between myopic deformation and autonomic dysfunction.
Collapse
|
15
|
O’Neill J, Bounford K, Anstey A, D’Silva J, Clark L, Plein S, Tayebjee MH. P wave indices, heart rate variability and anthropometry in a healthy South Asian population. PLoS One 2019; 14:e0220662. [PMID: 31442233 PMCID: PMC6707586 DOI: 10.1371/journal.pone.0220662] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2019] [Accepted: 07/19/2019] [Indexed: 12/19/2022] Open
Abstract
Background South Asians have a low prevalence of atrial fibrillation (AF) in comparison with White Europeans despite a higher burden of hypertension, diabetes mellitus and coronary artery disease. The reason for this disparity is unclear but may relate to electrophysiological or structural differences within the atria or variations in autonomic function. We aimed to assess these areas using a range of non-invasive cardiac investigations. Methods A prospective cohort study was performed on 200 South Asian and 200 Caucasian healthy volunteers aged 18–40 years. All subjects underwent electrocardiography (ECG), echocardiography and anthropometric measurements. Eighty subjects in each cohort underwent 24 hour ambulatory ECG and fifty subjects in each cohort underwent exercise testing. Results Compared with White Europeans, South Asians were of a smaller height with lower lean body mass and smaller left atrial size. They had reduced P wave dispersion and P wave terminal force in lead V1. South Asians had a lower burden of supraventricular ectopy. They had a higher mean heart rate and South Asian males had lower heart rate variability, suggestive of sympathetic predominance. Exercise capacity was lower in South Asians. Conclusions South Asians have differences in left atrial size, P wave indices, burden of supraventricular ectopy, heart rate, heart rate variability and anthropometric measurements. These differences may relate to variations in atrial morphology, atrial electrophysiology and autonomic function and might help to explain why South Asians are less susceptible to developing AF.
Collapse
Affiliation(s)
- James O’Neill
- Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds, United Kingdom
- * E-mail: james.o’
| | - Katrina Bounford
- Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds, United Kingdom
| | - Alice Anstey
- Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds, United Kingdom
| | - Jesvita D’Silva
- Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds, United Kingdom
| | - Lisa Clark
- Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds, United Kingdom
| | - Sven Plein
- Multidisciplinary Cardiovascular Research Centre (MCRC) and Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
| | - Muzahir H. Tayebjee
- Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds, United Kingdom
| |
Collapse
|
16
|
Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, Egan BM, Flack JM, Gidding SS, Judd E, Lackland DT, Laffer CL, Newton-Cheh C, Smith SM, Taler SJ, Textor SC, Turan TN, White WB. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension 2019; 72:e53-e90. [PMID: 30354828 DOI: 10.1161/hyp.0000000000000084] [Citation(s) in RCA: 572] [Impact Index Per Article: 114.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a patient despite the concurrent use of 3 antihypertensive drug classes, commonly including a long-acting calcium channel blocker, a blocker of the renin-angiotensin system (angiotensin-converting enzyme inhibitor or angiotensin receptor blocker), and a diuretic. The antihypertensive drugs should be administered at maximum or maximally tolerated daily doses. RH also includes patients whose BP achieves target values on ≥4 antihypertensive medications. The diagnosis of RH requires assurance of antihypertensive medication adherence and exclusion of the "white-coat effect" (office BP above goal but out-of-office BP at or below target). The importance of RH is underscored by the associated risk of adverse outcomes compared with non-RH. This article is an updated American Heart Association scientific statement on the detection, evaluation, and management of RH. Once antihypertensive medication adherence is confirmed and out-of-office BP recordings exclude a white-coat effect, evaluation includes identification of contributing lifestyle issues, detection of drugs interfering with antihypertensive medication effectiveness, screening for secondary hypertension, and assessment of target organ damage. Management of RH includes maximization of lifestyle interventions, use of long-acting thiazide-like diuretics (chlorthalidone or indapamide), addition of a mineralocorticoid receptor antagonist (spironolactone or eplerenone), and, if BP remains elevated, stepwise addition of antihypertensive drugs with complementary mechanisms of action to lower BP. If BP remains uncontrolled, referral to a hypertension specialist is advised.
Collapse
|
17
|
Value of Assessing Autonomic Nervous Function by Heart Rate Variability and Heart Rate Turbulence in Hypertensive Patients. Int J Hypertens 2018; 2018:4067601. [PMID: 30405909 PMCID: PMC6204178 DOI: 10.1155/2018/4067601] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2018] [Accepted: 09/26/2018] [Indexed: 11/18/2022] Open
Abstract
Purpose To explore the relationship between blood pressure control and autonomic nervous function assessing by heart rate variability (HRV) and heart rate turbulence (HRT) in hypertensive patients. Methods A total of 120 consecutive hypertensive patients and 80 nonhypertensive patients (N-HP group) were enrolled in this study. The hypertensive patients were divided into controlled blood pressure and uncontrolled blood pressure groups according to their blood pressure on admission. All subjects underwent 24-hour Holter monitoring. This study compared HRV and HRT in nonhypertensive and hypertensive patients and hypertensive patients with controlled and uncontrolled blood pressure. HRV parameters include square root of mean of the sum of squares of successive NN interval differences (rMSSD), number of successive NN intervals differing by > 50ms divided by the total number of successive NN intervals (pNN50), very low frequency (VLF) at frequency between 0.0033 and 0.04 Hz, low frequency (LF) at frequency between 0.04 and 0.15 Hz, and high frequency (HF) at frequency between 0.15 and 0.4 Hz. Turbulence slope (TS) belongs to HRT parameters. Results TS, rMSSD, pNN50, VLF, LF, and HF values were significantly lower in the HP group than in the N-HP group. Multiple logistic regression analysis showed that reduced TS, rMSSD, pNN50, LF, and HF values were risk factors of hypertension. TS, rMSSD, pNN50, VLF, LF, and HF values were significantly lower in hypertensive patients with uncontrolled blood pressure than in hypertensive patients with controlled blood pressure. Multiple logistic regression analysis showed that reduced TS, rMSSD, pNN50, VLF, LF, and HF values were risk factors for uncontrolled blood pressure. Conclusions This study indicates impaired autonomic nervous function in hypertensive patients, especially in hypertensive patients with uncontrolled blood pressure despite guideline recommended antihypertensive medications.
Collapse
|
18
|
Wang Q, Cui Y, Yogendranath P, Wang N. Blood pressure and heart rate variability are linked with hyperphosphatemia in chronic kidney disease patients. Chronobiol Int 2018; 35:1329-1334. [PMID: 29947550 DOI: 10.1080/07420528.2018.1486850] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Hyperphosphatemia is a common complication of chronic kidney disease (CKD) and is associated with cardiovascular disease (CVD), which has contributed to an increase in mortality of CKD patients. The onset of CVD often varies by time-of-day. Acute myocardial infarction or ventricular arrhythmia occurs most frequently during early morning. Blood pressure (BP) and heart rate circadian rhythms account for the diurnal variations in CVD. Preservation of normal circadian time structure from the cardiomyocyte level to the whole organ system is essential for cardiovascular health and CVD prevention. Independent risk factors, such as reduced heart rate variability (HRV) and increased BP variability (BPV), are particularly prevalent in patients with CKD. Analysis of HRV is an important clinical tool for characterizing cardiac autonomic status, and reduced HRV has prognostic significance for various types of CVD. Circadian BP rhythms are classified as extreme dipper, dipper, non-dipper or riser. It has been reported that nocturnal riser BP pattern contributes to cardiovascular threats. Previous studies have indicated that the circadian rhythm of serum phosphate in CKD patients is consistent with the general population, with the highest diurnal value observed in the early morning hours, followed by a progressive decrease to the lowest value of the day, which occurs around 11:00 am. Rhythm abnormalities have become the main therapeutic target for treating CVD in CKD patients. It has been reported that high levels of serum phosphate are associated with reduced HRV and increased BPV in CKD patients. However, the mechanisms related to interactions between hyperphosphatemia, HRV and BPV have not been fully elucidated. This review focuses on the evidence and discusses the potential mechanisms related to the effects of hyperphosphatemia on HRV and BPV.
Collapse
Affiliation(s)
- Qingting Wang
- a Department of Nephrology , the First Affiliated Hospital of Nanjing Medical University , Nanjing , China
| | - Ying Cui
- a Department of Nephrology , the First Affiliated Hospital of Nanjing Medical University , Nanjing , China
| | - Purrunsing Yogendranath
- a Department of Nephrology , the First Affiliated Hospital of Nanjing Medical University , Nanjing , China
| | - Ningning Wang
- a Department of Nephrology , the First Affiliated Hospital of Nanjing Medical University , Nanjing , China
| |
Collapse
|
19
|
Abstract
PURPOSE OF REVIEW Emerging evidence suggests that multiple mechanisms may be responsible for the development of treatment-resistant hypertension (TRH). This review aims to summarize recent data on potential mechanisms of resistance and discuss current pharmacotherapeutic options available in the management of TRH. RECENT FINDINGS Excess sodium and fluid retention, increased activation of the renin-angiotensin-aldosterone system, and heightened activity of the sympathetic nervous system appear to play an important role in development of TRH. Emerging evidence also suggests a role for arterial stiffness and, potentially, gut dysbiosis. Therapeutic approaches for TRH should include diuretic optimization and the addition of aldosterone antagonists as the preferred fourth agent in most patients. Further therapeutic approaches may be guided by the suspected underlying mechanism of TRH in conjunction with other patient-specific factors. The pathophysiology of TRH is multifaceted; however, increasing evidence supports several mechanisms that may be targeted to improve blood pressure control among patients with TRH. Further studies are needed to determine whether such approaches may be more effective than usual care.
Collapse
|
20
|
Sherwood A, Smith PJ, Hinderliter AL, Georgiades A, Blumenthal JA. Effects of exercise and stress management training on nighttime blood pressure dipping in patients with coronary heart disease: A randomized, controlled trial. Am Heart J 2017; 183:85-90. [PMID: 27979046 DOI: 10.1016/j.ahj.2016.10.011] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/04/2016] [Accepted: 10/17/2016] [Indexed: 02/07/2023]
Abstract
INTRODUCTION Blunted nighttime blood pressure (BP) dipping is prognostic of cardiovascular morbidity and mortality. Patients with coronary heart disease (CHD) are often characterized by a blunted nighttime BP dipping pattern. The present study compared the effects of 2 behavioral intervention programs, aerobic exercise (EX) and stress management (SM) training, with a usual care (UC) control group on BP dipping in a sample of CHD patients. METHODS This was a secondary analysis of a randomized, controlled trial with allocation concealment and blinded outcome assessment in 134 patients with stable CHD and exercise-induced myocardial ischemia. Nighttime BP dipping was assessed by 24-hour ambulatory BP monitoring, at prerandomization baseline and after 16 weeks of one of the following treatments: usual medical care; UC plus supervised aerobic EX for 35 minutes, 3 times per week; UC plus weekly 1.5-hour sessions of SM training. RESULTS The EX and SM groups exhibited greater improvements in systolic BP dipping (P=.052) and diastolic BP dipping (P=.031) compared with UC. Postintervention systolic BP percent-dipping means were 12.9% (SE=1.5) for SM, 11.1% (SE=1.4) for EX, and 8.6% (SE=1.4) for UC. Postintervention diastolic BP percent-dipping means were 13.3% (SE=1.9) for SM, 14.1% (SE=1.8) for EX, and 8.8% (1.8) for UC. CONCLUSIONS For patients with stable CHD, EX or SM training resulted in improved nighttime BP dipping compared with usual medical care. These favorable effects of healthy lifestyle modifications may help reduce the risk of adverse clinical events.
Collapse
|
21
|
Därr R, Bursztyn M, Pamporaki C, Peitzsch M, Siegert G, Bornstein SR, Eisenhofer G. Dipping in Ambulatory Blood Pressure Monitoring Correlates With Overnight Urinary Excretion of Catecholamines and Sodium. J Clin Hypertens (Greenwich) 2016; 18:921-6. [PMID: 26864704 PMCID: PMC8031512 DOI: 10.1111/jch.12791] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2015] [Revised: 12/05/2015] [Accepted: 12/10/2015] [Indexed: 11/30/2022]
Abstract
Nondipping blood pressure (BP) is associated with increased morbidity and mortality. This study examines the relationship of "dipping" in 24-hour ambulatory BP monitoring (ABPM) with awake and sleeping urinary norepinephrine (NE) and epinephrine (EPI), and that of urinary NE and EPI with urinary sodium (UNa). Fifty nondippers and 65 dippers were included in the present study. Collected data included age, sex, body mass index, history of hypertension, current antihypertensive treatment, ABPM data, and NE, EPI, and UNa values. Hierarchical multiple regression analysis with the night-to-day ratio (NDR) of systolic BP as a dependent variable showed that the composite term of the NDRs of urinary NE and EPI was a significant predictor for dipping. Results also show a differential role of NE and EPI in circadian UNa excretion in dippers and nondippers. These results indicate that the sympathetic nervous system is involved in the regulation of circadian BP variations and UNa excretion.
Collapse
Affiliation(s)
- Roland Därr
- Department of Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany. ,
| | - Michael Bursztyn
- Department of Medicine, Hypertension Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
| | - Christina Pamporaki
- Department of Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany
| | - Mirko Peitzsch
- Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany
| | - Gabriele Siegert
- Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany
| | - Stefan R Bornstein
- Department of Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany
| | - Graeme Eisenhofer
- Department of Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany
- Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany
| |
Collapse
|
22
|
Does sympathetic overactivation feature all hypertensives? Differences of sympathovagal balance according to night/day blood pressure ratio in patients with essential hypertension. Hypertens Res 2016; 39:440-8. [PMID: 26865002 DOI: 10.1038/hr.2016.6] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2015] [Revised: 11/14/2015] [Accepted: 12/14/2015] [Indexed: 12/20/2022]
Abstract
When evaluating the 'night/day BP ratio', both hypertensives and normotensives can be arbitrarily classified into four groups: extreme dippers (ratio ⩽0.8), dippers (0.8<ratio ⩽0.9), mild dippers (0.9<ratio⩽1.0) and reverse dippers (ratio ⩾1.0). Reverse and mild dipper hypertensives have poorer prognoses compared with the physiological dipper profile, but the prognostic relevance of the extreme dipper profile remains uncertain. The evaluation of heart rate variability (HRV), obtained by 24-h Holter ECG monitoring, is the most frequently used noninvasive form of assessment of the activity of the autonomic nervous system. Reverse and mild dipper hypertensives have reduced HRV, indicating an overactivation of the sympathetic nervous system (SNS); however, the HRV behavior in extreme dippers is still controversial. The goal of this study was to compare HRV indexes of extreme vs. reverse dipper essential hypertensives measured on the basis of time domains. We enrolled 125 hypertensive subjects, divided in 4 quartiles according to day/night blood pressure (BP) ratios. The upper and lower quartiles (31 subjects per quartile) were compared; 30 normotensive subjects were enrolled as a control group. Time domain HRV parameters of the three groups revealed a higher degree of sympathetic activation in the lower quartile (reverse dipper) vs. the upper quartile (extreme) and normotensive controls. HRV parameters related to parasympathetic tone did not show any significant variations among the three groups. Contrary to common belief, not all hypertensives have SNS overactivation.
Collapse
|
23
|
Rong S, Zhu H, Liu D, Qian J, Zhou K, Zhu Q, Jiang Y, Yang G, Deng C, Zhang D, Zhou Q, Lei H, He TC, Wang Z, Huang J. Noninvasive renal denervation for resistant hypertension using high-intensity focused ultrasound. Hypertension 2015; 66:e22-5. [PMID: 26238444 DOI: 10.1161/hypertensionaha.115.05754] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2015] [Accepted: 07/06/2015] [Indexed: 01/18/2023]
Affiliation(s)
- Shunkang Rong
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Hui Zhu
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Dichuan Liu
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Jun Qian
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Kun Zhou
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Que Zhu
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Yonghong Jiang
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Gang Yang
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Changming Deng
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Dengqing Zhang
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Qi Zhou
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Han Lei
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Tong-Chuan He
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Zhibiao Wang
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.)
| | - Jing Huang
- From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (S.R., D.L., J.Q., Q. Zhu, Y.J., G.Y., C.D., D.Z., Q. Zhou, J.H.); the Clinical Center for HIFU Tumor Therapy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.Z., K.Z.); the Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (H.L.); Molecular Oncology Laboratory, Department of Orthopedic Surgery, The University of Chicago Medical Center, IL (T.-C.H.); and National Engineering Research Center of Ultrasound Medicine, Chongqing, China (Z.W.).
| |
Collapse
|